<DOC>
	<DOCNO>NCT02295592</DOCNO>
	<brief_summary>TSTstarr+ treatment severe hemorrhoid prolapse -- A multi center randomize controlled clinical trial.The aim stuy compare first year hemorrhoid recurrence rate TSTstarr+ PPH treatment severe hemorrhoid .</brief_summary>
	<brief_title>TSTstarr + Treatment Severe Prolapsed Hemorrhoids -- - Multi-center Randomized Controlled Clinical Trail</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>severe prolapse hemorrhoid significant analmalformation operation sign informed consent . needing emergency operation previous history hemorrhoid operation anal disease time : anal fissure , anal fistula perianal abscess diagnose inflammatory bowel disease proctitis diagnose colorectal cancer associate cardiovascular cerebrovascular disease diseases tolerate surgery increase risk surgery chronic acute renal insufficiency patient coagulation abnormality anticoagulation treatment present diagnose diabetes poor glycemic control woman pregnant menstruation The intellectual disability mental disorder participate clinical trial select 4 week severe complication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>hemorrhoid</keyword>
	<keyword>The recurrence rate</keyword>
	<keyword>PPH</keyword>
	<keyword>TSTstarr+</keyword>
</DOC>